AIA forces changes in invention capture and review procedures: study

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

AIA forces changes in invention capture and review procedures: study

The America Invents Act has prompted many companies to make changes in their invention capture and review procedures and public disclosure polices, according to a study released by IP advisory firm ipPerformance

Compared to study results released in 2012 before implementation of the AIA, roughly double the companies indicated that they made changes in invention capture and submission stage versus their preparation and filing stage.

Some 85% of companies indicated that the AIA has influenced them to make public disclosure of an invention prior to patent filing policy changes. A third of companies indicated that the increase in USPTO fees will cause an increase to their patent budget.

“America Invents Act has encouraged companies to adapt their procedures, workflows and policies. The increased fees as well as pre and post grant proceedings are major factors that are impacting budgeting and strategy,” said Robert Williamson, president at ipPerformance Group.

Fifty-nine companies representing a variety of industries participated in the study, including Air Liquide, Nova Chemical, Sun Chemical, Dow Corning Corporation, Nova Measuring Instruments, ZBD, Avebe, Sasol, Neste Oil, Micro Encoder, Automotive Technologies and Freescale Semiconductor.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article